日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma.

rucaparib 联合 PLX038A 治疗浆液性子宫内膜癌的抗肿瘤活性

Hou Xiaonan, Zanfagnin Valentina, Xu Conway, Jessen Erik, Liu Yuanhang, Wang Chen, Huang Yajue, Fontaine Shaun D, Santi Daniel V, Colon-Otero Gerardo, Gill Sarah E, Glaser Gretchen E, Butler Kristina A, Bakkum-Gamez Jamie N, Dowdy Sean C, Oberg Ann L, Larson Melissa C, Atkinson Hunter J, Duffield Laura N, Peterson Kevin L, Kaufmann Scott H, Weroha S John

A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel

一份用通俗易懂的语言总结了接受多斯他利单抗联合卡铂-紫杉醇治疗的子宫内膜癌患者的生存情况的报告。

Powell, Matthew A; Bjørge, Line; Willmott, Lyndsay; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Gropp-Meier, Martina; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Segev, Yakir; Gill, Sarah E; Gennigens, Christine; Sebastianelli, Alexandra; Shahin, Mark S; Pothuri, Bhavana; Monk, Bradley J; Buscema, Joseph; Coleman, Robert L; Slomovitz, Brian M; Ring, Kari L; Herzog, Thomas J; Balas, Morad Marco; Grimshaw, Matthew; Stevens, Shadi; Lai, Dominic W; McCourt, Carolyn; Mirza, Mansoor Raza

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

“多斯利单抗治疗原发性晚期或复发性子宫内膜癌”的简明语言摘要

Mirza, Mansoor R; Chase, Dana M; Slomovitz, Brian M; Christensen, René dePont; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Hanker, Lars C; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S; Gill, Sarah E; Monk, Bradley J; Buscema, Joseph; Herzog, Thomas J; Copeland, Larry J; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L; Powell, Matthew A

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

鲁索替尼联合一线新辅助治疗晚期卵巢癌的I期和随机II期研究:NRG肿瘤协作组研究

Landen, Charles N; Buckanovich, Ronald J; Sill, Michael W; Mannel, Robert S; Walker, Joan L; DiSilvestro, Paul A; Mathews, Cara A; Mutch, David G; Hernandez, Marcia L; Martin, Lainie P; Bishop, Erin; Gill, Sarah E; Gordinier, Mary E; Burger, Robert A; Aghajanian, Carol; Liu, Joyce F; Moore, Kathleen N; Bookman, Michael A

A diverse portfolio of marine protected areas can better advance global conservation and equity

多样化的海洋保护区可以更好地促进全球保护和公平

David A Gill, Sarah E Lester, Christopher M Free, Alexander Pfaff, Edwin Iversen, Brian J Reich, Shu Yang, Gabby Ahmadia, Dominic A Andradi-Brown, Emily S Darling, Graham J Edgar, Helen E Fox, Jonas Geldmann, Duong Trung Le, Michael B Mascia, Roosevelt Mesa-Gutiérrez, Peter J Mumby, Laura Veverka, L

Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR

研究影响靶向 MISIIR 的人源单克隆抗体 3C23K 疗效的因素

Gill, Sarah E; Zhang, Qing; Keeney, Gary L; Cliby, William A; Weroha, S John

Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis

骨关节炎中骨软骨连接处和骨赘中的神经血管侵犯

Suri, Sunita; Gill, Sarah E; Massena de Camin, Sally; Wilson, Deborah; McWilliams, Daniel F; Walsh, David A